[1]
Svensson M.K., James S., Ravn-Fischer A., Villa G., Schalin L., Cars T., Gustafsson S. and Hagström E. 2024. A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels. Upsala Journal of Medical Sciences. 129, (Feb. 2024), e9618. DOI:https://doi.org/10.48101/ujms.v129.9618.